Literature DB >> 27836405

Radioembolization of Hepatic Malignancies: Background, Quality Improvement Guidelines, and Future Directions.

Siddharth A Padia1, Robert J Lewandowski2, Guy E Johnson3, Daniel Y Sze4, Thomas J Ward5, Ron C Gaba6, Mark O Baerlocher7, Vanessa L Gates2, Ahsun Riaz2, Daniel B Brown8, Nasir H Siddiqi9, T Gregory Walker10, James E Silberzweig11, Jason W Mitchell12, Boris Nikolic13, Riad Salem2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27836405     DOI: 10.1016/j.jvir.2016.09.024

Source DB:  PubMed          Journal:  J Vasc Interv Radiol        ISSN: 1051-0443            Impact factor:   3.464


× No keyword cloud information.
  27 in total

Review 1.  Yttrium-90 Radiation Segmentectomy.

Authors:  Guy E Johnson; Siddharth A Padia
Journal:  Semin Intervent Radiol       Date:  2020-12-11       Impact factor: 1.513

2.  Yttrium-90 radioembolization treatment for unresectable hepatocellular carcinoma: a single-centre prognostic factors analysis.

Authors:  C Floridi; F Pesapane; S A Angileri; D De Palma; F Fontana; F Caspani; A Barile; A Del Sole; C Masciocchi; G Lucignani; G Carrafiello
Journal:  Med Oncol       Date:  2017-09-05       Impact factor: 3.064

Review 3.  Yttrium-90 Radioembolization for Metastatic Colorectal Cancer: Outcomes by Number of Lines of Therapy.

Authors:  Andrew Marsala; Edward W Lee; Siddharth A Padia
Journal:  Semin Intervent Radiol       Date:  2017-06-01       Impact factor: 1.513

4.  Prognostic factors of unresectable hepatocellular carcinoma treated with yttrium-90 radioembolization: results from a large cohort over 13 years at a single center.

Authors:  Rucha M Shah; Sarah Sheikh; Jimmy Shah; Elaina Vivian; Alejandro Mejia; Islam Shahin; Parvez S Mantry
Journal:  J Gastrointest Oncol       Date:  2021-08

5.  Radioembolization With Chemotherapy for Colorectal Liver Metastases: A Randomized, Open-Label, International, Multicenter, Phase III Trial.

Authors:  Mary F Mulcahy; Armeen Mahvash; Marc Pracht; Amir H Montazeri; Steve Bandula; Robert C G Martin; Ken Herrmann; Ewan Brown; Darryl Zuckerman; Gregory Wilson; Tae-You Kim; Andrew Weaver; Paul Ross; William P Harris; Janet Graham; Jamie Mills; Alfonso Yubero Esteban; Matthew S Johnson; Constantinos T Sofocleous; Siddharth A Padia; Robert J Lewandowski; Etienne Garin; Philip Sinclair; Riad Salem
Journal:  J Clin Oncol       Date:  2021-09-20       Impact factor: 44.544

6.  Combination of 1st and 2nd Week Dosing of Glass Yttrium-90 Microspheres for Superselective Radioembolization.

Authors:  Hyo-Cheol Kim; Myungsu Lee; Jeong-Hoon Lee; Jin Chul Paeng; Yoon Jun Kim; Jin Wook Chung
Journal:  In Vivo       Date:  2020 Sep-Oct       Impact factor: 2.155

7.  Transarterial radioembolization in patients with hepatocellular carcinoma of intermediate B2 substage.

Authors:  Alberta Cappelli; Paloma Sangro; Cristina Mosconi; Iris Deppe; Eleonora Terzi; Jose I Bilbao; Macarena Rodriguez-Fraile; Caterina De Benedittis; Jens Ricke; Rita Golfieri; Bruno Sangro
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-09-12       Impact factor: 9.236

Review 8.  Safety of selective internal radiation therapy (SIRT) with yttrium-90 microspheres combined with systemic anticancer agents: expert consensus.

Authors:  Andrew Kennedy; Daniel B Brown; Jonas Feilchenfeldt; John Marshall; Harpreet Wasan; Marwan Fakih; Peter Gibbs; Alexander Knuth; Bruno Sangro; Michael C Soulen; Gianfranco Pittari; Ricky A Sharma
Journal:  J Gastrointest Oncol       Date:  2017-12

9.  Incidence and risk factors for sustained hepatic function toxicity 6 months after radioembolization: analysis of the radiation-emitting sir-spheres in non-resectable liver tumor (RESIN) registry.

Authors:  Daniel Brown; Henry Krebs; Jayson Brower; Ryan O'Hara; Eric Wang; Kirubahara Vaheesan; Liping Du; Lea Matsuoka; Donna D'Souza; Daniel Y Sze; Jafar Golzarian; Ripal Gandhi; Andrew Kennedy
Journal:  J Gastrointest Oncol       Date:  2021-04

10.  Safety and initial efficacy of radiation segmentectomy for the treatment of hepatic metastases​.

Authors:  Craig Meiers; Amy Taylor; Brian Geller; Beau Toskich
Journal:  J Gastrointest Oncol       Date:  2018-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.